News Zonisade Approved to Treat Seizures July 15, 2022 Read More » Xalkori Granted New Indication to Treat Non-Cancerous Tumors July 14, 2022 Read More » Diacomit Approved for Broader Age Group July 14, 2022 Read More » Krystexxa Approved for Use with Methotrexate July 8, 2022 Read More » Comirnaty Receives Full FDA Approval for Expanded Age Group July 8, 2022 Read More » Mylan Recalls One Lot of Insulin Glargine July 6, 2022 Read More » Pharmacists Now Able to Prescribe Paxlovid July 6, 2022 Read More » Brand Medications with Generic Alternatives Anticipated to be Approved in July July 1, 2022 Read More » Copiktra May Increase Risk for Cancer Patients June 30, 2022 Read More » Page1 … Page23 Page24 Page25 Page26 Page27 … Page38 Benefit Advisors & Employees - Want to know more? Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager Full Name(Required)Email(Required) Comment(Required)Company Name(Required)CAPTCHA
Brand Medications with Generic Alternatives Anticipated to be Approved in July July 1, 2022 Read More »